Composition of peptide mixtures derived from simulated gastrointestinal digestion of prolamins from different wheat varieties

Journal of Cereal Science

Volumn 56, Issue 2, 2012, Pages 223-231

  Prandi, Barbara ^a   Bencivenni, Mariangela ^a   Faccini, Andrea ^a   Tedeschi, Tullia ^a   Dossena, Arnaldo ^a   Marchelli, Rosangela ^a   Galaverna, Gianni ^a   Sforza, Stefano ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Celiac disease; Gliadin; Simulated gastrointestinal digestion; Wheat varieties

Indexed keywords

TRITICUM AESTIVUM; TRITICUM TURGIDUM; TRITICUM TURGIDUM SUBSP. DURUM;

EID: 84865992698     PISSN: 07335210     EISSN: 10959963     Source Type: Journal    
DOI: 10.1016/j.jcs.2012.04.008     Document Type: Article

References (33)

1. Arentz-Hansen H., Korner R., Molberg O., Quarsten H., Vader W., Kooy Y.M., Lundin K.E., Koning F., Roepstorff P., Sollid L.M., McAdam S.N. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. Journal of Experimental Medicine 2000, 191:603-612.
2. Arentz-Hansen H., McAdam S.N., Molberg O., Fleckenstein B., Lundin K.E., Jorgensen T.J., Jung G., Roepstorff P., Sollid L.M. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002, 123:803-809.
3. Catassi C., Kryszak D., Bhatti B., Sturgeon C., Helzlsouer K., Clipp S.L., Gelfond D., Puppa E., Sferruzza A., Fasano A. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Annals of Medicine 2010, 42:530-538.
4. Cavatorta V., Sforza S., Aquino G., Galaverna G., Dossena A., Pastorello E.A., Marchelli R. In vitro gastrointestinal digestion of the major peach allergen Pru P 3, a lipid transfer protein: molecular characterization of the products and assessment of their IgE binding abilities. Molecular Nutrition & Food Research 2010, 54:1452-1457.
5. Ciccocioppo R., Di Sabatino A., Corazza G.R. The immune recognition of gluten in celiac disease. Clinical and Experimental Immunology 2005, 140:408-416.
6. Clemente M.G., De Virgilis S., Kang J.S., Macatagney R., Musu M.P., Di Pierro R.M., Drago S., Congia M., Fasano A. Early effects of gliadin on enterocyte intracellular signaling involved in intestinal barrier function. Gut 2003, 2:218-223.
7. Commission Regulation (EC) No 41/2009 of 20 January 2009 concerning the composition and labelling of foodstuffs suitable for people intolerant to gluten.
8. Cornell H.J. Coeliac disease: a review of the causative agents and their possibly mechanisms of action. Amino Acids 1996, 10:1-19.
9. Cornell H.J., Wills-Johnson D. Structure activity relationship in celiac-toxic gliadin peptides. Amino Acids 2001, 21:243-253.
10. De Ritis G., Auricchio S., Jones H.W., Lew E.J.L., Bernardin J.E., Kasarda D.D. "In vitro" (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology 1988, 94:41-49.
11. Farrell R.J., Kelly C.P. Celiac sprue. New England Journal of Medicine 2002, 346:180-188.
12. Gianfrani C., Auricchio S., Troncone R. Adaptive and innate immune responses in celiac disease. Immunology Letters 2005, 99:141-145.
13. Gobetti M., Rizzello G.M., Di Cagno R., De Angelis M. Sour-dough lactobacilli and celiac disease. Food Microbiology 2007, 24:187-196.
14. Ivarsson A., Hernell O., Stenlund H., Åke Persson L. Breast-feeding protects against celiac disease. American Journal of Clinical Nutrition 2002, 75:914-921.
15. Londei M., Ciacci C., Ricciardelli I., Vacca L., Quarantino S., Maiuri L. Gliadin as a stimulator of innate responses in celiac disease. Molecular Immunology 2005, 42:913-918.
16. Mamone G., Ferranti P., Rossi M., Roepstorff P., Fierro O., Malori A., Addeo F. Identification of a peptide from α-gliadin resistant to digestive enzymes: implications for celiac disease. Journal of Chromatography B 2007, 855:236-241.
17. Matysiak-Budnik T., Candalh C., Dugave C., Namane A., Cellier C., Cerf-Bensussan N., Heyman M. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 2003, 125:696-707.
18. Molberg O., McAdam S.N., Korner R., Quarsten H., Kristiansen C., Madsen L., Fugger L., Scott H., Norén O., Roepstorff P., Lundin K.E.A., Sjöström H., Sollid L.M. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Medicine 1998, 4:713-717.
19. Nilsen E.M., Jahnsen F.L., Lundin K.E., Johansen F.E., Fausa O., Sollid L.M., Jahnsen J., Scott H., Brandtzaeg P. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998, 115:551-563.
20. Osborne T.R. The Protein of the Wheat Kernel 1907, Carnegie Inst. Publ.
21. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G.M., Sollid L.M., Khosla C. Structural basis for gluten intolerance in celiac disease. Science 2002, 297:2275-2279.
22. Shewry P.R., Tatham A.S., Kasarda D.D. Cereal proteins and celiac disease. Celiac Disease 1992, 305-348. Blackwell, Oxford. M. Marsh (Ed.).
23. Sollid L.M. Molecular basis of celiac disease. Annual Review of Immunology 2000, 18:53-81.
24. Sollid L.M., Lie B.A. Celiac disease genetics: current concepts and practical applications. Clinical Gastroenterology and Hepatology 2005, 3:843-851.
25. Spaenij-Dekking L., Koning F. The molecular basis of celiac disease. Molecular Autoimmunity 2005, 3:141-150.
26. Stepniak D., Spaenij-Dekking L., Mitea C., Moester M., de Ru A., Baak-Pablo R., van Veelen P., Edens L., Koning F. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006, 291:621-629.
27. Trier J.S. Diagnosis of celiac disease. Gastroenterology 1998, 115:211-216.
28. Tye-Din J.A., Stewart J.A., Dromey J.A., Beissbarth T., van Heel D.A., Tatham A., Henderson K., Mannering S.I., Gianfrani C., Jewell D.P., Hill A.V.S., McCluskey J., Rossjohn J., Anderson R.P. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Science Translational Medicine 2010, 2:41-51.
29. Vader W., Kooy Y., Van Veelen P., De Ru A., Harris D., Benckhuijsen W., Peña S., Mearin L., Drijfhout J.W., Koning F. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002, 122:1729-1737.
30. Van de Wal Y., Kooy I., Van Veelen P., Pena S., Mearin L., Papadopoulos G., Koning F. Selective deamidation by tissue transglutaminase strongly enhances gliadin specific T-cell reactivity. Journal of Immunology 1998, 161:1585-1588.
31. Van de Wal Y., Kooy Y.M., Van Veelen P.A., Pena S.A., Mearin L.M., Molberg O., Lundin K.E., Sollid L.M., Mutis T., Benckhuijsen W.E., Drijfhout J.W., Koning F. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:10050-10054.
32. Wieser H. Relation between gliadin structure and celiac toxicity. Acta Pædiatrica Supplement 1996, 412:3-9.
33. Wieser H. Comparative investigations of gluten proteins from different wheat species. I. Qualitative and quantitative composition of gluten protein types. European Food Research and Technology 2000, 211:262-268.